ScholarIQanswers from OpenAlex

Drug treatments for covid-19: living systematic review and network meta-analysis

PaperCitations, authors & open-access status

Drug treatments for covid-19: living systematic review and network meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Drug treatments for covid-19: living systematic review and network meta-analysis have?

ScholarIQcitation count

Drug treatments for covid-19: living systematic review and network meta-analysis has 912 citations in the OpenAlex counts ScholarIQ stores.

When was Drug treatments for covid-19: living systematic review and network meta-analysis published?

ScholarIQyear

Drug treatments for covid-19: living systematic review and network meta-analysis has 2020 year in the ScholarIQ index.

What is the open-access status of Drug treatments for covid-19: living systematic review and network meta-analysis?

ScholarIQoa status

Drug treatments for covid-19: living systematic review and network meta-analysis has hybrid oa status in the ScholarIQ index.

What is the DOI of Drug treatments for covid-19: living systematic review and network meta-analysis?

ScholarIQdoi

The DOI for Drug treatments for covid-19: living systematic review and network meta-analysis is on the source record.

What is the PMID of Drug treatments for covid-19: living systematic review and network meta-analysis?

ScholarIQpmid

The PMID for Drug treatments for covid-19: living systematic review and network meta-analysis is on the source record.

What is the OpenAlex record for Drug treatments for covid-19: living systematic review and network meta-analysis?

ScholarIQopenalex

The OpenAlex for Drug treatments for covid-19: living systematic review and network meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial